Moderators: gotinearly , Bigfootbud , pumper_stumper , Carter , Huggy Bear , joe botts
Search This Board: 
Created: 09/03/2014 10:04:29 AM - Followers: 1124 - Board type: Free - Posts Today: 102

Picture

Regen BioPharma 
 

 0.000x  Ticker Symbol: RGBP 

Barchart



All other Regen BioPharma News
https://www.regenbiopharmainc.com/company-news.html




 
 

Regen BioPharma, Inc. 4700 Spring Street, Suite 304
La Mesa, CA 91942 U.S.A.


Telephone: (619) 702-1404
Fax: (619) 330-2328




Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP)  focused on the immunology and immunotherapy space. The Company plans to rapidly advance novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is advancing small molecule therapies for treating cancer and autoimmune disorders by modulating the Checkpoint NR2F6.  The company also developing products treating blood disorders using small molecules and gene silencing (DiffronC), treating cancer with cellular immunotherapy (dCellVax), modulating key molecular processes in cancer stem cell through its patented molecular targeting approaches (BORIS), and repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients (HemaXellerate).






 

Product Pipeline | Regen BioPharma, Inc.

Small Molecules Targeting Cancer and Autoimmunity

Regen has identified and filed patents on small molecules that activate and inhibit a novel gene (NR2F6) which controls how the immune system reacts to cancer cells and to inflammatory responses.
  • Objective is to identify small molecules that can activate and inhibit NR2F6
    ?Currently in pre-clinical development 
    Initial indications (inhibitor): bladder cancer, myelodysplastic syndrome, lung cancer
    Initial indications (activator): rheumatoid arthritis, inflammatory bowel disease, psoriasis
    Additional indications include solid tumors, acute leukemia and GVHD
 

HemaXellerate

Aplastic Anemia Stem Cell Therapy – HemaXellerate – IND #15376 CLEARED TO PROCEED TO PHASE I / II CLINICAL TRIALS
HemaXellerate is a personalized cellular therapeutic product designed to stimulate blood production in patients whose bone marrow is not properly functioning.
  • Fat stem cell based product to treat bone marrow that has been damaged
    Bone marrow damage occurs from radiation, chemo, or chronic conditions
    HemaXellerate uses patient’s own fat as source of endothelial cells to heal damaged bone marrow 
    ?United States Food and Drug Administration Investigational New Drug Application cleared (IND #15376)



     

dCellVax 

Breast Cancer – dCellVax - IND #16200
CellVax is a dendritic cell based immunotherapy that stimulates the patient’s immune system through a process called “gene silencing.”
  • 10 advanced breast cancer patients
    Efficacy endpoints at 6 and 12 months
    Establishment of safety will allow for rapid expansion of patient numbers 
    Currently addressing FDA questions with Dr. Santosh Kesari, head of UCSD Neuro-Oncology program 


     

DiffronC

Myelodysplastic Syndrome Gene Silencing – DiffronC
DiffronC is a novel form of therapy called differentiation therapy that is expected to have much milder toxicity than chemotherapy. The mechanism of action is to correct the specific genes that prevent the myelodysplastic syndrome stem cell from producing mature blood cells.
  • siRNA silencing of our newly discovered cancer stem cell target gene
    Silencing using DiffronC induces differentiation of cancer cells 
    Initial indication is treatment of myelodysplastic syndrome 
    Other indications include solid tumors and acute leukemia



     

Telomeres & Genomic Integrity

Stem cells and cancer cells have found ways of maintaining their telomeres in a state that prevents senescence. Our research in to the cancer stem cell has given us a molecular pathway that can be manipulated to expand stem cells and maintain telomeres.
  • Telomeres are protective structures at the ends of chromosomes that enable cell divisions
    Telomere attrition is involved in aging, cancer and genetic mutations 
    We are developing drugs that modulate telomere maintenance 
    In pre-clinical development for indications of solid cancers and acute leukemia



     
 

 






Share Dilution History
 
 
Date
Outsanding Shares
4/7/22 4,736,002,832
5/16/22 4,820,002,832
7/1/22 4,920,002,832
   
   
   
   



2022 Updates RGBP FAQ

1)  Q: I've seen claims that RGBP has a product or products currently in Phase 1 or Phase 2 testing.  Is this true?
A:  Not a single document singed by the company, nor a single PR released by the company mentions ANY current FDA approved lab doing any Phase 1 or Phase 2 testing for RGBP.   This will be updated, as soon as either of those are provided!   Note, "clearance" is not testing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
#110399
New 8-K Filing - Debt gone! TexasLearner 07/20/2022 07:49:39 PM
#106600
1 BILLION new shares authorized, necessary, due to pumper_stumper 04/03/2022 09:39:30 PM
#41420
RGBP/Zander patents... gotinearly 03/29/2021 01:43:29 PM
#111982
LOL "Valid examples" that do not meet pumper_stumper 08/11/2022 08:22:51 PM
#111981
“Changing the topic says it all!” I’d agree, you’ve Dyno89 08/11/2022 08:10:55 PM
#111980
Looks to me like 34 valid, linked examples Dyno89 08/11/2022 08:10:03 PM
#111979
Actually RGBP new lows coming call was in 29YEARINVESTOR 08/11/2022 08:09:24 PM
#111978
Looks to me like legitimate, verifiable, factual links Dyno89 08/11/2022 08:06:32 PM
#111977
Kind of like changing the topic from the Dyno89 08/11/2022 08:02:33 PM
#111976
Misinformation and misdirection is the name of the SidVicious 08/11/2022 08:02:11 PM
#111975
There it is! Mic drop! No pumper_stumper 08/11/2022 07:52:15 PM
#111974
WRONG Did I blink? If so, I would 29YEARINVESTOR 08/11/2022 07:50:16 PM
#111973
MEGA SUPER DUPER WRONG AGAIN. pumper_stumper 08/11/2022 07:47:57 PM
#111972
I agree BonnieMac 08/11/2022 07:42:05 PM
#111971
Thank you for your impeccable dd and factual Dyno89 08/11/2022 07:37:41 PM
#111970
Super Duper Wrong Again! Can I find the 29YEARINVESTOR 08/11/2022 07:16:43 PM
#111969
Shhhhhhhhhh…. buy/out no buy/out we are djocks 08/11/2022 07:08:59 PM
#111967
WRONG AGAIN, of course I was referring to pumper_stumper 08/11/2022 06:56:02 PM
#111966
WRONG! Another False statement! All it takes is 29YEARINVESTOR 08/11/2022 06:50:53 PM
#111965
Wrong! Where’s them .0025 and triple digits lows 29YEARINVESTOR 08/11/2022 06:32:28 PM
#111963
Nothing here answered my question. LesMoore 08/11/2022 06:26:13 PM
#111962
Suspense/Surprise is a good strategy raja48185 08/11/2022 05:50:56 PM
#111961
Might be Pre-Market, might be at Open, might Here Today 08/11/2022 05:45:08 PM
#111960
You gotta luv how Dr Koos will keep Here Today 08/11/2022 05:44:17 PM
#111958
Let's envision you are a CEO of a SidVicious 08/11/2022 05:39:12 PM
#111957
So thankful!!!!! joe botts 08/11/2022 05:31:04 PM
#111956
And you know this how? LesMoore 08/11/2022 05:28:14 PM
#111955
And the “GRAND SLAM” portion of the PR Here Today 08/11/2022 05:27:07 PM
#111954
This is one key part of PR: David Koos, Here Today 08/11/2022 05:25:57 PM
#111950
Wow nice!!!! Thanks joe botts 08/11/2022 04:58:10 PM
#111949
Your statement is the most valuable and dangerous Fdc4 08/11/2022 04:56:51 PM
#111948
Just because this has been sub penny for StocktonCA 08/11/2022 04:48:16 PM
#111947
Thank you Schuller. RGBP has a huge twitter LesMoore 08/11/2022 04:45:10 PM
#111946
Thanks for your input new guy!! Johnnie Ringo 08/11/2022 04:37:40 PM
#111945
Are you saying this might be a PR pumper_stumper 08/11/2022 04:36:51 PM
#111944
And if true then Lolo's prediction will be Schuller 08/11/2022 04:35:36 PM
#111942
Thanks for the vote of confidence. Schuller 08/11/2022 04:33:02 PM
#111941
... fishing with live bait - no plastic lures Rushnattack 08/11/2022 04:15:28 PM
#111940
of course, first they would have to call StocktonCA 08/11/2022 04:15:19 PM
#111939
OTCShotCaller Listen, as you and I know, Koos art35 08/11/2022 04:13:56 PM
#111938
Very savvy indeed. Should make the big boys SidVicious 08/11/2022 04:10:57 PM
#111937
They are selling for me. Love them for SidVicious 08/11/2022 04:10:12 PM
#111936
I think it was very Savvy for Koos StocktonCA 08/11/2022 04:08:13 PM
#111935
rgbp--->koosimodo_PUT_DA_PPS_IN_CEMENT_SLIPPERS_&_FLUSHED_IT!!! Sat Naam 08/11/2022 04:01:48 PM
#111933
fluffy news? droopyeyes 08/11/2022 03:56:06 PM
#111932
RGBP CHART IS LOOKING STRONG! 9 SMA sherman106 08/11/2022 03:54:00 PM
#111931
If it looks like dilution is probably is, JAM 08/11/2022 03:53:10 PM
#111930
And remember folks our president announced continued aggressive stokbrokin 08/11/2022 03:52:18 PM
#111929
Try here: santjers 08/11/2022 03:52:02 PM
#111928
Is STXG diluting here? I took a MAGA_PATRIOT 08/11/2022 03:51:25 PM
#111926
Hey Schuller, I trust your input. LesMoore 08/11/2022 03:47:02 PM
#111925
Oh lordy! SidVicious 08/11/2022 03:45:19 PM
#111924
That it's "No Joke"? santjers 08/11/2022 03:44:12 PM
Post Subject